Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant - PA: Genetics (Bridge Funding: Research Priorities)

University of Calgary

$100,000.00

The function and regulation of short-stature genes during limb development and chondrogenesis

FY 2014-15

Summary
As many as 1 in 1,000 people are estimated to have short limbs because of disruptions of the SHOX gene. A strikingly large number (perhaps 35%) of these limb abnormalities are caused by DNA deletions that don't include the SHOX gene itself, but instead remove sequences distant from the gene. These sequences are thought to contain what are known as enhancers. Unlike genes, enhancer sequences do not code for proteins, but instead they control the expression of genes on the same chromosome. In this proposal, we will use transgenic mice to define precisely the sequences that have this SHOX enhancer activity. We have also found that a closely related gene in mice called Shox2 is necessary for normal limb development, much like human SHOX. Therefore, we are studying the mechanism of SHOX gene function using the mouse Shox2 gene as a model, including the identification of enhancers controlling Shox2 gene expression. The SHOX and SHOX2 genes code for proteins called transcription factors that regulate the expression of other genes, called targets. These target genes are mostly unknown. Therefore in this proposal we will identify SHOX2 target genes to help us learn more about why disruption of these genes causes limb deformities, and how we might be able to intervene in the process.
Program
Operating Grant - PA: Genetics (Bridge Funding: Research Priorities)
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
330132
Name
Cobb John A
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Developmental Biology
Projecttitle
The function and regulation of short-stature genes during limb development and chondrogenesis
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: Genetics (Bridge Funding: Research Priorities)
Keyworddelim
Chondrogenesis; Enhancers; Genomic Architecture; Genomics; Leri Weill Dyschondrosteosis; Limb Development; Mouse Genetics; Transcription Factors; Transgenesis; Turner Syndrome
Abstract
As many as 1 in 1,000 people are estimated to have short limbs because of disruptions of the SHOX gene. A strikingly large number (perhaps 35%) of these limb abnormalities are caused by DNA deletions that don't include the SHOX gene itself, but instead remove sequences distant from the gene. These sequences are thought to contain what are known as enhancers. Unlike genes, enhancer sequences do not code for proteins, but instead they control the expression of genes on the same chromosome. In this proposal, we will use transgenic mice to define precisely the sequences that have this SHOX enhancer activity. We have also found that a closely related gene in mice called Shox2 is necessary for normal limb development, much like human SHOX. Therefore, we are studying the mechanism of SHOX gene function using the mouse Shox2 gene as a model, including the identification of enhancers controlling Shox2 gene expression. The SHOX and SHOX2 genes code for proteins called transcription factors that regulate the expression of other genes, called targets. These target genes are mostly unknown. Therefore in this proposal we will identify SHOX2 target genes to help us learn more about why disruption of these genes causes limb deformities, and how we might be able to intervene in the process.
Competitiondate
201503
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cobb, John A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~
University of Calgary - $100,000 Grant (2014-15) | Canada Spends